Collegium Pharmaceutical Inc (COLL)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $786.83M
Last updated: Nov 17, 2026 at 11:04 AM ET
Collegium Pharmaceutical Inc (COLL) P/E Ratio & Valuation History
Collegium Pharmaceutical (COLL) trades at 3.7x trailing earnings and 1.0x sales. Its P/E of 3.7x is below its 5-year median of 6.2x. Its forward P/E is 3.7x. The median P/E across 11 similar companies is 10.7x.
Current Multiples
Its enterprise value is 4.9x its EBITDA. Its free cash flow yield is 41.7%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 3.7x |
| Forward P/E | 3.7x |
| Price to sales | 1.0x |
| Price to book | 2.7x |
| EV/EBITDA | 4.9x |
| Price to FCF | 2.4x |
| EV/FCF | 5.2x |
| PEG | 0.7 |
| FCF yield | 41.7% |
Historical Medians
Against its 10-year medians, its P/S is 50.0% below 2.0x and its P/B is 35.7% below 4.2x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 3.7x | 6.2x | N/A |
| P/S | 1.0x | 1.7x | 2.0x |
| P/B | 2.7x | 4.1x | 4.2x |
Valuation History
Over the 7 of the 10 year ends shown that have a P/E, its P/E ranged from 4.4x in 2024 to 82.3x in 2019.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $46.30 | 6.6x | 2.0x | 6.1x |
| 2024 | $28.65 | 4.4x | 1.6x | 5.0x |
| 2023 | $30.78 | 5.6x | 2.0x | 6.6x |
| 2022 | $23.20 | 7.7x | 1.7x | 4.0x |
| 2021 | $18.68 | 9.2x | 2.4x | 3.1x |
| 2020 | $20.03 | 9.1x | 2.2x | 3.8x |
| 2019 | $20.58 | 82.3x | 2.3x | 7.9x |
| 2018 | $17.17 | N/A | 2.0x | 6.3x |
| 2017 | $18.46 | N/A | 20.0x | 5.8x |
| 2016 | $15.57 | N/A | 237.8x | 3.1x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About COLL
What is COLL's forward P/E ratio?
Collegium Pharmaceutical has a forward P/E ratio of 3.7x.
Is COLL stock overvalued?
GNG's valuation label for COLL is Undervalued. Its P/E of 3.7x compares with a median of 10.7x across 11 similar companies.
What is COLL's price to sales ratio?
Collegium Pharmaceutical has a price to sales ratio of 1.0x.
What is Collegium Pharmaceutical's average P/E ratio over 5 years?
Collegium Pharmaceutical's median P/E over the last 5 years is 6.2x, from 60 month-end values through Oct 2026.
What is COLL's PEG ratio?
Collegium Pharmaceutical has a PEG ratio of 0.7.
COLL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors